Sinofn Health
Sinofn Health
Advanced metabolic support formulations engineered for international distribution channels, prioritizing bioavailability and climatic stability.
Kaédi, the administrative center of the Gorgol Region in southern Mauritania, sits as a pivotal geographic hub along the Senegal River. Positioned within the complex climate profiles of the Sahel, this area presents a critical demand for specialized nutritional therapeutics, specifically Foods for Special Medical Purposes (FSMP). Clinical management of metabolic disorders, childhood wasting, and maternal nutritional shortfalls requires highly targeted intervention profiles that standard food supplies fail to deliver.
By connecting SINOFN's advanced biotechnology infrastructure with regional pharmaceutical and medical distribution companies in Kaédi, we resolve the acute deficit of medical grade food formulations. The challenges of hot climate storage are countered with our advanced encapsulation processes and robust packaging systems, facilitating direct, reliable distribution to local clinics, NGOs, and hospitals throughout Gorgol and neighboring zones.
Our collaborative industrial pipeline matches strict global GMP standards with local requirements, ensuring that vital formulas, such as amino acid profiles for PKU and total nutrient admixtures, survive the transit logistics of West Africa without degradation of the bioactive components.
Using specialized dual-layer barriers and nitrogen-flushed packaging, we prevent nutrient oxidation under thermal environments up to 45°C.
Full adherence to WHO Codex Alimentarius standards, ensuring that raw material selection and production lines are audit-ready for international organizations.
Science-Driven OEM for Global Supplement & FSMP Brands
SINOFN Health Co., Ltd. is the dedicated contract manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established globally in 2025, our international business operation is managed from Shanghai, acting as the trading gateway for global partners seeking premium, clinical-grade medical foods and food supplements.
During her early clinical practice, Mrs. GuoHong Liu witnessed the continuous struggles of PKU (Phenylketonuria) children and their families, for whom specialized metabolic diets were financially out of reach due to heavy import reliance. Driven to bridge this critical market gap, she founded SINOFN in 2012 to research and develop affordable, highly localized, science-backed PKU foods and FSMPs.
Her commitment quickly attracted strategic academic and industrial partners, leading to structural growth from PKU-specific solutions to comprehensive FSMPs, clinical enteral nutrition, and high-efficacy nutraceuticals. Guided by the principle of "Profit with Purpose", SINOFN actively commits resources to global PKU accessibility initiatives, while collaborating with top scientific institutions like the Chinese Academy of Sciences (Tianjin R&D center) to build an accessible legacy of health.
"We measure success not just in revenue, but in lives improved through accessible clinical science." – Mrs. GuoHong Liu, Founder
Integrating elite clinical insight with academic support to drive next-generation nutritional engineering.
Associate Researcher & Chinese Academy of Sciences (CAS) Postdoc. Specializes in advanced bioactive compound delivery systems and nutrient micro-encapsulation technologies.
Ph.D. from Peking University Medical School. Over 15 years of dedicated experience in metabolic disorder formulations and clinical trial design for FSMPs.
Senior Scientist from the Netherlands. Expert in EU and global regulatory structures for medical foods, leading process industrialization and special dietary foods.
Addressing the challenges of compliance, bio-stability, and security in the modern medical food supply chain.
Industrial sourcing of FSMP (Foods for Special Medical Purposes) products goes beyond standard commodity procurement. It requires rigorous alignment with medical regulations, specialized formula stability, and verified manufacturing traceability. For institutions procuring clinical nutrition products for deployment in West African nodes like Kaédi, or major healthcare centers globally, we provide structured, high-capacity solutions designed to resolve typical supply chain challenges:
For patients with Phenylketonuria (PKU), precise formulation control is essential. We use raw materials that are completely free from phenylalanine while ensuring taste acceptability through advanced flavor-masking techniques.
Delivering fast, digestible calories to post-operative patients or those suffering from clinical wasting. Our micro-emulsions maintain stability without phase separation over prolonged shelf lives.
Proprietary mixing systems ensure completely uniform distribution of vitamins and trace minerals, preventing toxic accumulation or localized ingredient deficiency in dry powder formats.
Procuring clinical-grade nutrients often involves significant import markups. By optimizing our manufacturing costs through advanced pilot-scale dry-blending automation, and using raw materials authenticated under HACCP protocols, SINOFN bridges the financial gap for hospitals and aid agencies. We handle complex international export clearances, supplying certifications compliant with both FDA guidelines and national health departments in Africa and Europe.
Our long-term R&D plan focuses on bringing cutting-edge biopharmaceutical standards to clinical food production. By collaborating with leading postdoctoral institutes, we are moving toward target-specific nutrition profiles:
As we expand our distribution capabilities in West Africa, Kaédi serves as a practical model for implementing sustainable, heat-stable nutritional solutions that do not rely on cold-chain infrastructure.
"By stabilizing clinical formulas through targeted micro-encapsulation, we protect the molecular structure of amino acids from the extreme ambient temperatures of dry regions. This ensures that when our products reach remote medical centers, they deliver their full intended nutritional therapeutic value."
Equipped with state-of-the-art technologies to guarantee safety, potency, and compliance at scale.
10+ dedicated automated lines for softgels, gummies, and powders.
Certified under ISO 22000, HACCP, and FSSC 22000 protocols.
Annual capacity: 500 million+ finished units.
Inquire Capacity
Equipped with HPLC and GC-MS equipment for active substance verification.
Comprehensive microbiological safety and toxin screening.
Accelerated stability and dissolution testing programs.
Request QA Dossier
Pilot-scale testing for tablets, capsules, and therapeutic liquids.
Optimized bioavailability testing across diverse age ranges.
Advanced stability chambers matching Zone IV climatic conditions.
Request Prototype
Seamless workflow from raw materials to final packaging.
Blockchain batch tracking system for total supply chain visibility.
BRCGS-certified storage and climate-controlled warehousing.
Trace Supply ChainSINOFN prioritizes intellectual property and strict manufacturing standards, holding 36 patents (including 11 invention, 12 utility model, 11 software copyrights, and 2 designs) along with 71 multi-category trademarks. Our facilities maintain ISO9001, ISO22000, HACCP, and HALAL certifications, ensuring compliance for international markets.
Explore our formulations, developed for healthcare providers, metabolic diet systems, and therapeutic sports brands globally.
Get answers to common technical, geographical, and clinical questions regarding our FSMP and specialty nutrition manufacturing.
Whether you are expanding medical food access in West Africa, supplying clinics in Kaédi, or developing targeted metabolic formulas for international markets, our teams in Shanghai and Tianjin are ready to support you.
Send Inquiry Now